Company research / RCUS
Arcus Biosciences, Inc. (RCUS)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Arcus Biosciences, Inc. reported revenue of $247.00M. Revenue fell 4.3% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $117.00M.
Key ratios (year ended 2025-12-31)
-156.3%
Operating margin
-142.9%
Net margin
-55.9%
Return on year-end equity
-4.3%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.